A multitasking oncolytic adenovirus vector

Molecular Therapy

Volumn 7, Issue 4, 2003, Pages 435-437

  Toth, Karoly ^a   Doronin, Konstantin ^a   Tollefson, Ann E ^a   Wold, William S M ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DIPHOSPHATE; ADENOVIRUS VECTOR; COMPLEMENTARY DNA; TUMOR NECROSIS FACTOR ALPHA; VIRUS DNA; VIRUS PROTEIN;

ALTERNATIVE RNA SPLICING; ARTICLE; BYSTANDER EFFECT; CELL DEATH; CELL DESTRUCTION; GENE CASSETTE; GENE DELETION; GENE EXPRESSION; GENE REPLACEMENT THERAPY; GENETIC ENGINEERING; METASTASIS; PROMOTER REGION; PROTEIN SECRETION; SIMIAN VIRUS 40; VIRUS INFECTION; VIRUS RECOMBINANT; VIRUS REPLICATION;

ADENOVIRIDAE; DNA VIRUSES; SIMIAE; SIMIAN VIRUS 40;

EID: 0038523778     PISSN: 15250016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1525-0016(03)00071-6     Document Type: Article

References (20)

1. Green, N. K., and Seymour, L. W. (2002). Adenoviral vectors: systemic delivery and tumor targeting. Cancer Gene Ther. 9: 1036-1042.
2. Bauzon, M., Castro, D., Karr, M., Hawkins, L. K., and Hermiston, T. W. (2003). Regulated, multi-gene expression from a replicating adenovirus using native viral promoters. Mol. Ther., this issue.
3. Reid, T., Warren, R., and Kirn, D. (2002). Intravascular adenoviral agents in cancer patients: lessons from clinical trials. Cancer Gene Ther. 9: 979-986.
4. Hermiston, T. W., and Kuhn, I. (2002). Armed therapeutic viruses: strategies and challenges to arming oncolytic viruses with therapeutic genes. Cancer Gene Ther. 9: 1022-1035.
5. Kelly, T. J. Jr., and Lewis, A. M. Jr. (1973). Use of non-defective adenovirus-simian virus 40 hybrids for mapping the simian virus 40 genome. J. Virol. 12: 643-652.
6. Horwitz, M. (2001). Adenovirus immunoregulatory genes and their cellular targets. Virology 279: 1-8.
7. Mahr, J. A., and Gooding, L. R. (1999). Immune evasion by adenoviruses. Immunol. Rev. 168: 121-130.
8. Wold, W. S. M., Doronin, K., Toth, K., Kuppuswamy, M., Lichtenstein, D. L., and Tollefson, A. E. (1999). Immune responses to adenoviruses: viral evasion mechanisms and their implications for the clinic. Curr. Opin. Immunol. 11: 380-386.
9. Ginsberg, H. S., Lundholm-Beauchamp, U., Horswood, R. L., Pernis, B., Wold, W. S. M., Chanock, R. M., and Prince, G. A. (1989). Role of early region 3 (E3) in pathogenesis of adenovirus disease. Proc. Natl. Acad. Sci. USA 86: 3823-3827.
10. Bhat, B. M., and Wold, W. S. M. (1986). Genetic analysis of mRNA synthesis in adenovirus region E3 at different stages of productive infection by RNA-processing mutants. J. Virol. 60: 54-63.
11. Tollefson, A. E., Scaria, A., Saha, S. K., and Wold, W. S. M. (1992). The 11,600-MW protein encoded by region E3 of adenovirus is expressed early but is greatly amplified at late stages of infection. J. Virol. 66: 3633-3642.
12. Hawkins, L. K., Johnson, L., Bauzon, M., Nye, J. A., Castro, D., Kitzes, G. A., Young, M. D., Holt, J. K., Trown, P., and Hermiston, T. W. (2001). Gene delivery from the E3 region of replicating human adenovirus: evaluation of the 6.7K/gp19K region. Gene Ther. 8: 1123-1131.
13. Hawkins, L. K., and Hermiston, T. (2001). Gene delivery from the E3 region of replicating human adenovirus: evaluation of the E3B region. Gene Ther. 8: 1142-1148.
14. Hawkins, L. K., and Hermiston, T. W. (2001). Gene delivery from the E3 region of replicating human adenovirus: evaluation of the ADP region. Gene Ther. 8: 1132-1141.
15. Tollefson, A. E., Scaria, A., Hermiston, T. W., Ryerse, J. S., Wold, L. J., and Wold, W. S. M. (1996). The adenovirus death protein (E3-11.6K) is required at very late stages of infection for efficient cell lysis and release of adenovirus from infected cells. J. Virol. 70: 2296-2306.
16. Brady, H. A., Scaria, A., and Wold, W. S. M. (1992). Map of cis-acting sequences that determine alternative pre-mRNA processing in the E3 complex transcription unit of adenovirus. J. Virol. 66: 5914-5923.
17. Scaria, A., and Wold, W. S. M. (1994). Fine-mapping of sequences that suppress splicing in the E3 complex transcription unit of adenovirus. Virology 205: 406-416.
18. Tollefson, A. E., Ryerse, J. S., Scaria, A., Hermiston, T. W., and Wold, W. S. M. (1996). The E3-11.6kDa Adenovirus Death Protein (ADP) is required for efficient cell death: characterization of cells infected with adp mutants. Virology 220: 152-162.
19. Doronin, K., Toth, K., Kuppuswamy, M., Ward, P., Tollefson, A. E., and Wold, W. S. M. (2000). Tumor-specific, replication-competent adenovirus vectors overexpressing the Adenovirus Death Protein. J. Virol. 74: 6147-6155.
20. Doronin, K., Toth, K., Kuppuswamy, M., Krajcsi, P., Tollefson, A. E., and Wold, W. S. M. (2003). Overexpression of the ADP (E3-11.6K) protein increases cell lysis and spread of adenovirus. Virology 305: 378-387.